Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced ...
Allysia Finley is a member of the Journal's Editorial Board. Ms. Finley joined The Wall Street Journal in 2009 after graduating from Stanford University with a bachelor’s degree in American Studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback